Brian Cummings, UCI professor of physical medicine & rehabilitation and founding member of the Sue & Bill Gross Stem Cell Research Center, has received a five-year, $2.7 million grant from the California Institute for Regenerative Medicine to establish a training program that supports first-generation and underserved students pursuing careers in public health and regenerative medicine. […]
Sue & Bill Gross Stem Cell Research Center seeks to demystify its work with public lecture series, open houses
UCI stem cell scientist Brian Cummings was awarded a $4.8 million grant from the California Institute for Regenerative Medicine, the state’s stem cell agency. This grant will support the only CIRM-funded program addressing traumatic brain injury in California. TBIs are a leading cause of death & disability worldwide, and two million Americans annually (230,000 Californians) […]
UCI stem cell researchers have received $1.6 million from the California Institute for Regenerative Medicine to create a new line of neural stem cells that can be used to treat chronicle cervical spinal cord injury. Aileen Anderson, director of the Sue & Bill Gross Stem Cell Research Center at UCI, will lead the effort. The […]
Brian Cummings and Aileen Anderson of UCI’s Sue & Bill Gross Stem Cell Research Center are among this year’s “Hottest 25 People in O.C.,” a designation conferred annually by OC Metro, Orange County’s leading business magazine.
From Oct. 1 to 3, the Sue & Bill Gross Stem Cell Research Center joins an international awareness effort, hosting events for local students, the campus community and UCI supporters.
UC Irvine scientists will be part of two research teams garnering CIRM Disease Team Therapy Development Awards, which are designed to accelerate collaborative translational research leading to human clinical trials.
Swiss doctors with the world’s first clinical trial using human neural stem cells to treat chronic thoracic spinal cord injury report that two patients have regained some ability to feel touch and heat.
Grant from state stem cell research funding agency will advance joint project to treat spinal cord injury.
Doctors with the Balgrist University Hospital in Zurich report that the surgery, immunosuppression and cell transplants have been well tolerated.